FDA Peptide Classifications
The FDA categorizes peptides into distinct regulatory pathways that determine their legal status and availability. Understanding these classifications is crucial for researchers navigating the complex peptide landscape.
Approved Medications
FDA-approved peptide drugs like Semaglutide and Oxytocin have completed rigorous clinical trials and require prescriptions. These compounds have established safety profiles and specific therapeutic indications. Off-label prescribing by licensed physicians is legally permitted for approved peptides.
Investigational New Drugs (INDs)
Peptides like Kisspeptin-10 and Larazotide exist under IND status, meaning they're in active clinical trials but not yet approved for general use. These compounds are restricted to clinical research settings under FDA oversight.
Cosmetic Ingredients
Topical peptides including GHK-Cu and SNAP-8 fall under cosmetic regulations when used in skincare formulations. They're generally recognized as safe for topical application but cannot make drug claims about treating medical conditions.
Compounding Pharmacy Access
Some peptides like Sermorelin are available through compounding pharmacies under specific regulations. These require prescriptions and must be prepared according to USP standards.
Gray Market Realities
Many research peptides exist in regulatory gray areas, sold as "research chemicals" with "not for human consumption" labels. This labeling attempts to circumvent drug regulations but doesn't change the underlying legal framework.
This information is for research and educational purposes only. Consult qualified professionals for regulatory compliance guidance.